- Description
- Table of Contents
- Request Sample
The Global Cancer Immunotherapy market is expected to reach $21, 138, 1.9 million by 2026 growing at a CAGR of 15.2% during 2018 to 2026. Cancer immunotherapy is a kind of cancer treatment that boosts the human bodys natural immune system to fight against the cancer cells. This therapy is provided to cancer patients to prevent the spread of cancer, to slow down the growth of cancer cells, and to improve the natural immunity for destroying the cancer cells. Technological advancements in treatment therapies and increase in healthcare expenditure and healthcare insurance are some of the factors driving the market growth. Though, lack of experienced healthcare professionals is restraining the market. Based on Application, Lung Cancer has witnessed the significant growth due to rise in occurrence and patient pool urges a demand for advanced treatment options are some of the factors driving the market growth. The key vendors mentioned are Pfizer Inc., Merck & Co., Inc., F. Hoffmann-La Roche, Amgen, Inc., JOHNSON & JOHNSON, AstraZeneca , GlaxoSmithKline Plc., Novartis Ag, Precision BioSciences, Inc., Janssen Biotech, Inc. and Bristol-Myers Squibb Co. Products Covered: • Checkpoint Inhibitors • Oncoloytic Viral Therapies and Cancer Vaccines • Monoclonal Antibodies • Cellular Immunotherapy • Cytokine Therapy • Bacillus Calmette-Guérin Applications Covered: • Colorectal Cancer • Prostate Cancer • Ovarian Cancer • Lung Cancer • Head and Neck Cancer • Pancreatic Cancer • Breast Cancer • Melanoma • Non-Small Cell Lung Cancer (NSCLC) • Renal Cell Carcinoma • Other Applications End Users Covered: • Clinics • Hospital • Cancer Research Centers • Ambulatory Surgical Centers (ASCs) Regions Covered: • North America • Europe • Asia Pacific • South America • Middle East & Africa Key Questions Answered in this Report: • How this market evolved since the year 2016 • Market size estimations, forecasts and CAGR for all the segments presented in the scope • Key Market Developments and financials of the key players • Opportunity Analysis for the new entrants • SWOT Analysis of the key players • Fastest growing markets analysed during the forecast period
1 Market Synopsis
2 Research Outline
2.1 Research Snapshot
2.2 Research Methodology
2.3 Research Sources
2.3.1 Primary Research Sources
2.3.2 Secondary Research Sources
3 Market Dynamics
3.1 Drivers
3.2 Restraints
4 Market Environment
4.1 Bargaining power of suppliers
4.2 Bargaining power of buyers
4.3 Threat of substitutes
4.4 Threat of new entrants
4.5 Competitive rivalry
5 Global Cancer Immunotherapy Market, By Product
5.1 Introduction
5.2 Checkpoint Inhibitors
5.3 Oncoloytic Viral Therapies and Cancer Vaccines
5.4 Monoclonal Antibodies
5.5 Cellular Immunotherapy
5.6 Cytokine Therapy
5.7 Bacillus Calmette-Guérin
6 Global Cancer Immunotherapy Market, By Application
6.1 Introduction
6.2 Colorectal Cancer
6.3 Prostate Cancer
6.4 Ovarian Cancer
6.5 Lung Cancer
6.6 Head and Neck Cancer
6.7 Pancreatic Cancer
6.8 Breast Cancer
6.9 Melanoma
6.10 Non-Small Cell Lung Cancer (NSCLC)
6.11 Renal Cell Carcinoma
6.12 Other Applications
7 Global Cancer Immunotherapy Market, By End User
7.1 Introduction
7.2 Clinics
7.3 Hospital
7.4 Cancer Research Centers
7.5 Ambulatory Surgical Centers (ASCs)
8 Global Cancer Immunotherapy Market, By Geography
8.1 Introduction
8.2 North America
8.3 Europe
8.4 Asia Pacific
8.5 South America
8.6 Middle East & Africa
9 Strategic Benchmarking
10 Vendors Landscape
10.1 Pfizer Inc.
10.2 Merck & Co., Inc.
10.3 F. Hoffmann-La Roche
10.4 Amgen, Inc.
10.5 JOHNSON & JOHNSON
10.6 AstraZeneca
10.7 GlaxoSmithKline Plc.
10.8 Novartis Ag
10.9 Precision BioSciences, Inc.
10.10 Janssen Biotech, Inc.
10.11 Bristol-Myers Squibb Co.
List of Data Tables
1 Global Cancer Immunotherapy Market Outlook, By Region (2016-2026) ($MN)
2 Global Cancer Immunotherapy Market Outlook, By Product (2016-2026) ($MN)
3 Global Cancer Immunotherapy Market Outlook, By Checkpoint Inhibitors (2016-2026) ($MN)
4 Global Cancer Immunotherapy Market Outlook, By Oncoloytic Viral Therapies and Cancer Vaccines (2016-2026) ($MN)
5 Global Cancer Immunotherapy Market Outlook, By Monoclonal Antibodies (2016-2026) ($MN)
6 Global Cancer Immunotherapy Market Outlook, By Cellular Immunotherapy (2016-2026) ($MN)
7 Global Cancer Immunotherapy Market Outlook, By Cytokine Therapy (2016-2026) ($MN)
8 Global Cancer Immunotherapy Market Outlook, By Bacillus Calmette-Guérin (2016-2026) ($MN)
9 Global Cancer Immunotherapy Market Outlook, By Application (2016-2026) ($MN)
10 Global Cancer Immunotherapy Market Outlook, By Colorectal Cancer (2016-2026) ($MN)
11 Global Cancer Immunotherapy Market Outlook, By Prostate Cancer (2016-2026) ($MN)
12 Global Cancer Immunotherapy Market Outlook, By Ovarian Cancer (2016-2026) ($MN)
13 Global Cancer Immunotherapy Market Outlook, By Lung Cancer (2016-2026) ($MN)
14 Global Cancer Immunotherapy Market Outlook, By Head and Neck Cancer (2016-2026) ($MN)
15 Global Cancer Immunotherapy Market Outlook, By Pancreatic Cancer (2016-2026) ($MN)
16 Global Cancer Immunotherapy Market Outlook, By Breast Cancer (2016-2026) ($MN)
17 Global Cancer Immunotherapy Market Outlook, By Melanoma (2016-2026) ($MN)
18 Global Cancer Immunotherapy Market Outlook, By Non-Small Cell Lung Cancer (NSCLC) (2016-2026) ($MN)
19 Global Cancer Immunotherapy Market Outlook, By Renal Cell Carcinoma (2016-2026) ($MN)
20 Global Cancer Immunotherapy Market Outlook, By Other Applications (2016-2026) ($MN)
21 Global Cancer Immunotherapy Market Outlook, By End User (2016-2026) ($MN)
22 Global Cancer Immunotherapy Market Outlook, By Clinics (2016-2026) ($MN)
23 Global Cancer Immunotherapy Market Outlook, By Hospital (2016-2026) ($MN)
24 Global Cancer Immunotherapy Market Outlook, By Cancer Research Centers (2016-2026) ($MN)
25 Global Cancer Immunotherapy Market Outlook, By Ambulatory Surgical Centers (ASCs) (2016-2026) ($MN)